Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
7.36
-0.49 (-6.24%)
At close: Aug 27, 2025, 4:00 PM
7.02
-0.34 (-4.62%)
After-hours: Aug 27, 2025, 7:20 PM EDT
Portage Biotech Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Portage Biotech.
Price Target: $ (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Portage Biotech.
Recommendation Trends
| Rating | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 | Jan '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $180 → $120 | Strong Buy | Maintains | $180 → $120 | +1,530.43% | Nov 29, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $220 | Buy | Reiterates | $220 | +2,889.13% | Sep 7, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $220 | Buy | Reiterates | $220 | +2,889.13% | Aug 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $420 → $180 | Strong Buy | Maintains | $420 → $180 | +2,345.65% | Aug 2, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.53
from -5.72
EPS Next Year
n/a
from -0.53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 |
|---|---|
| High | n/a |
| Avg | n/a |
| Low | n/a |
Revenue Growth
| Revenue Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
EPS Forecast
| EPS | 2026 |
|---|---|
| High | -0.55 |
| Avg | -0.53 |
| Low | -0.51 |
EPS Growth
| EPS Growth | 2026 |
|---|---|
| High | - |
| Avg | - |
| Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.